Table 1 Baseline characteristics of patients
Variables | TACE (n = 28) | TACE – MWA (n = 17) | P value |
|---|---|---|---|
Sex, n (%) | |||
Male | 24 | 15 | 1.000 |
Female | 4 | 2 | |
Age (years) | 58.25 ± 10.15 | 60.29 ± 9.90 | 0.512 |
Initial HCC resection data | |||
Size of resected HCC, median (IQR), cm | 3.5 (2.1–5.0) | 3.0 (1.7–5.5) | 0.277 |
No. of resected HCCs, median (IQR), n | 1.0 (1.0–1.0) | 1.0 (1.0–1.5) | 0.353 |
Edmonson grade, n (%) | |||
I | 12 | 8 | 0.572 |
II–III | 15 | 7 | |
III | 1 | 2 | |
BCLC stage, n (%) | |||
A | 25 | 16 | 1.000 |
B | 3 | 1 | |
Recurrence stage data | |||
Time to recurrence, median (IQR), days | 319 (31–1478) | 136(47–1872) | 0.008 |
Largest tumor size, median (IQR), cm | 1.6 (1.3–2.6) | 1.4 (1.1–2.0) | 0.452 |
Tumor number, median (IQR), n | 1.0 (1.0–2.0) | 1.0 (1.0–2.0) | 0.289 |
HBV, n (%) | |||
Yes | 28 | 17 | NA |
No | 0 | 0 | |
AFP, n (%) | |||
≥ 400 ng/mL | 5 | 2 | 0.693 |
< 400 ng/mL | 23 | 15 | |
PLT, median (IQR), 109/L | 113.0 (74.7–154.5) | 103.0 (84.0–159.0) | 0.842 |
ALT, median (IQR), IU/L | 25.1 (19.8–31.3) | 20.5 (15.5–25.5) | 0.055 |
AST, median (IQR), IU/L | 28.5 (21.3–40.9) | 22.9 (21.0–28.2) | 0.075 |
ALB, median (IQR), g/L | 39.0 (37.9–42.9) | 40.0 (36.5–44.6) | 0.870 |
TBIL, median (IQR), μmol/L | 15.3 (11.9–18.8) | 14.7 (12.7–18.3) | 0.935 |
PT, median (IQR), s | 12.6 (12.1–13.2) | 12.5 (12.0–13.1) | 0.439 |
INR, median (IQR) | 1.1 (1.0–1.2) | 1.1 (1.0–1.1) | 0.439 |
Child–Pugh, n (%) | |||
A | 26 | 17 | 0.519 |
B | 2 | 0 | |